 once-daili aminoglycosid therapi once-daili administr aminoglycosid attract concept anim experi clinic trial reduct influenc risk toxic less frequent dose contact time host tissu site drug thank pae as-yet-unrecogn factor fall level serum mic antibacteri efficaci fact peak level serum drug efficaci dosag interv neutropen patient vivo pae small-coloni variant pae concomit beta-lactam time data clinic trial unit avail result intern trial encourag potenti benefit patient reason infecti diseas consult educ process necessari once-daili aminoglycosid therapi institut